GO
Loading...

Dynavax Fell 47% Yesterday

Friday, 16 Nov 2012 | 6:45 PM ET

Yesterday, the FDA panel asked Dynavax Technologies to present more safety data on its Hepatitis B vaccination. The stock fell 47 percent on the news, and Mad Money host Jim Cramer offers a strategy to play the stock.